Matthew Wein
Title: General Counsel, Compliance Officer and Corporate Secretary · Metagenomi Therapeutics, Inc.
- 2025
- Sep 10, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew Wein files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Laurence Reid - $23K in MGX purchases and sales in the last 12 months
- Jian Irish - $16K in MGX purchases and sales in the last 12 months
- Pamela Wapnick - $14K in MGX purchases and sales in the last 12 months
- Brian C. Thomas - $12K in MGX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew Wein?
Matthew Wein is a corporate insider, tracked as Title: General Counsel, Compliance Officer and Corporate Secretary of Metagenomi Therapeutics, Inc. (MGX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Matthew Wein submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Matthew Wein been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($3K) across all tracked filings.
